Model applicable for patients with early-stage cervical cancer (T1a–T2b) after primary surgical treatment.
Model is developed on data from 4,343 patients treated in 20 tertiary centres on 4
It has been evaluated by 10-fold cross-validation within the imputed data set.
The resulting median
C index equals 0.732*
DFS represents a % probability of survival without disease recurrence at the respective time point.